UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 5, 2002
-----------------
I-TRAX, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-30275 23-3057155
------------------------ ------------ -------------------
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification No.)
One Logan Square
130 N. 18th St., Suite 2615
Philadelphia, PA 19103
--------------------------------------------- ---------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (215) 557-7488
N/A
-----------------------------------------------------
(Former name or former address, if changed since last report)
Item 9. Regulation FD Disclosure
Frank A. Martin, Chairman and CEO of I-trax, Inc., intends to disclose at a
meeting with broker/dealers and fund managers on November 5th that I-trax is in
the final stages of negotiating an acquisition of a company that conducts
business in the disease management market.
I-trax expects that a definitive agreement will be executed within the next
several days and that an announcement of the identity of the company and
significant terms of the agreement will be disclosed at that time.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
I-TRAX, INC.
Date: November 5, 2002 By: /s/ Anthony Tomaro, CPA
-----------------------------------
Name: Anthony Tomaro, CPA
Title: Chief Financial Officer